Malaria

Malaria is caused by a parasite called Plasmodium, which is transmitted via the bites of infected mosquitoes. In the human body, the parasites multiply in the liver, and then infect red blood cells.

Symptoms of malaria include fever, headache, and vomiting, and usually appear between 10 and 15 days after the mosquito bite. If not treated, malaria can quickly become life-threatening by disrupting the blood supply to vital organs. In many parts of the world, the parasites have developed resistance to a number of malaria medicines.

Key interventions to control malaria include: prompt and effective treatment with artemisinin-based combination therapies; use of insecticidal nets by people at risk; and indoor residual spraying with insecticide to control the vector mosquitoes.
Malaria Prevention

Levels of Prevention

Prevention of malaria can aim at either:

* preventing infection, by avoiding bites by parasite-carrying mosquitoes, or
* preventing disease, by using antimalarial drugs prophylactically. The drugs do not prevent initial infection through a mosquito bite, but they prevent the development of malaria parasites in the blood, which are the forms that cause disease. This type of prevention is also called "suppression."


6 Facts on malaria

Fact 1

About 40% of the world’s population, mostly those living in the poorest countries, are at risk of malaria. Of these 2.5 billion people at risk, more than 500 million people become severely ill with malaria every year and more than 1 million people die from the effects of the diseas


Fact 2

Early diagnosis and prompt treatment are two basic elements of malaria control. Early and effective treatment of malaria can shorten the duration of the infection and prevent further complications including the great majority of deaths. Access to disease management should be seen not only as a component of malaria control but a fundamental right of all populations at risk.


Fact 3

Inappropriate use of antimalarial drugs in the past century contributed to widespread resistance in the malaria parasite to drugs such as chloroquine, leading to rising rates of sickness and death. Over the past decade, a new group of antimalarials – known as artemisinin-based combination therapies – has brought new hope in the fight against malaria.


Fact 4

The main objective of malaria vector control is to significantly reduce the rate and number of cases of both parasite infection and clinical malaria. This is achieved by controlling the malaria-bearing mosquito and thereby reducing or interrupting transmission.


Fact 5

Long-lasting insecticidal nets can be used to provide protection to risk groups, especially young children and pregnant women in high transmission areas. This provides personal protection. The nets can also protect communities when coverage is high enough (more than 80% of people in a target community sleeping inside them). The nets are effective for a number of years (3 to 5 years, depending on models and conditions of use).


Fact 6

Pregnant women are at high risk not only of dying from the complications of severe malaria, but also spontaneous abortion, premature delivery or stillbirth. Malaria is also a cause of severe maternal anaemia and is responsible for about one third of preventable low birth weight babies. It contributes to the deaths of an estimated 10 000 pregnant women and up to
200 000 infants each year in Africa alone.